ProfileGDS4718 / 218496_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 88% 81% 93% 85% 84% 91% 88% 85% 84% 86% 86% 84% 84% 91% 86% 85% 83% 86% 90% 89% 84% 86% 84% 84% 86% 87% 87% 89% 85% 92% 88% 91% 79% 82% 87% 90% 88% 86% 82% 94% 83% 88% 85% 91% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.8542488
GSM549102patient 115, normal, homogenized [OPG study]7.8902181
GSM549104patient 119, normal, homogenized [OPG study]9.7531393
GSM549108patient 138, normal, homogenized [OPG study]8.4130385
GSM549119patient 077, normal, homogenized [OPG study]8.3147684
GSM549133patient 032, cancer, homogenized [OPG study]9.5182591
GSM549139patient 042, cancer, homogenized [OPG study]8.853388
GSM549099patient 107, normal, homogenized [OPG study]8.3995285
GSM549109patient 139, normal, homogenized [OPG study]8.336484
GSM549110patient 046, normal, homogenized [OPG study]8.5762486
GSM549114patient 063, normal, homogenized [OPG study]8.6629386
GSM549122patient 082, normal, homogenized [OPG study]8.3070984
GSM549134patient 033, cancer, homogenized [OPG study]8.3528884
GSM549136patient 036, cancer, homogenized [OPG study]9.3366891
GSM549140patient 044, cancer, homogenized [OPG study]8.6891686
GSM549111patient 047, normal, homogenized [OPG study]8.5584585
GSM549113patient 057, normal, homogenized [OPG study]8.4031783
GSM549132patient 031, cancer, homogenized [OPG study]8.6510786
GSM549137patient 038, cancer, homogenized [OPG study]9.0757290
GSM549142patient 047, cancer, homogenized [OPG study]8.6270889
GSM549100patient 110, normal, homogenized [OPG study]8.2881384
GSM549107patient 135, normal, homogenized [OPG study]8.6273186
GSM549115patient 068, normal, homogenized [OPG study]8.5008184
GSM549116patient 072, normal, homogenized [OPG study]8.462784
GSM549120patient 078, normal, homogenized [OPG study]8.6189786
GSM549131patient 030, cancer, homogenized [OPG study]8.8012687
GSM549118patient 074, normal, homogenized [OPG study]8.7415687
GSM549129patient 027, cancer, homogenized [OPG study]8.9082289
GSM549123patient 088, normal, homogenized [OPG study]8.5015685
GSM549124patient 006, cancer, homogenized [OPG study]9.394792
GSM549126patient 015, cancer, homogenized [OPG study]8.7849588
GSM549128patient 025, cancer, homogenized [OPG study]9.3711991
GSM549103patient 117, normal, homogenized [OPG study]7.6483479
GSM549117patient 073, normal, homogenized [OPG study]8.1579682
GSM549138patient 041, cancer, homogenized [OPG study]8.742187
GSM549141patient 045, cancer, homogenized [OPG study]9.3228790
GSM549130patient 028, cancer, homogenized [OPG study]8.8436988
GSM549101patient 111, normal, homogenized [OPG study]8.5088986
GSM549105patient 128, normal, homogenized [OPG study]8.1015782
GSM549106patient 134, normal, homogenized [OPG study]10.069594
GSM549112patient 048, normal, homogenized [OPG study]8.2756183
GSM549125patient 011, cancer, homogenized [OPG study]8.7719488
GSM549127patient 024, cancer, homogenized [OPG study]8.4287885
GSM549135patient 035, cancer, homogenized [OPG study]9.3855391